@2024 Afarand., IRAN
ISSN: 1735-7667 Iranian Journal of Military Medicine 2010;12(1):1-6
ISSN: 1735-7667 Iranian Journal of Military Medicine 2010;12(1):1-6
Risk factors of low bone mineral density in premenopausal women
ARTICLE INFO
Article Type
Original ResearchAuthors
Bayat N. (1)Hajiamini Z. ()
Alishiri Gh. H. (1)
Paydar M. (1)
Ebadi A. (2)
Parandeh A. (3)
Nuhi S. (4)
() “Behavioral Sciences Research Center” , “Faculty of Nursing”, Baqiyatallah University of Medical Sciences, Tehran, Iran
(1) Department of Romatology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
(1) Department of Romatology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
(2) Faculty of Nursing, Baqiyatallah University of Medical Sciences, Tehran, Iran
(3) Chemical Trauma Research Center, Baqiyatallah Institute of Medical Sciences, Tehran, Iran
(4) Department of Psychiatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Correspondence
Address:Phone:
Fax:
z_hajiamini@hotmail.com
Article History
Received: November 11, 2008Accepted: February 7, 2010
ePublished:
ABSTRACT
Aims
Osteoporosis is the most common metabolic bone disease, which is defined as a decrease in bone mass. This disease is known with the change and destruction or reduction of skeletal structure and increased risk of fracture. This study was conducted to investigate the risk factors in decreasing bone density in premenopausal women.
Methods In a descriptive cross-sectional study, 644 premenopausal women of military families who were referred to bone densitometry center of a hospital in Tehran participated in the research. Then, based on bone densitometry results the participants were divided into two groups: bone density loss 9 case groups) and normal bone density (control group). The information associated with risk factors of bone density loss were collected by osteoporosis Canadian standard questionnaire and was analyzed with chi square test and T-test.
Results Amount of spinal osteoporosis was 8.9% and the rate of osteopenia in these areas was 53.4%. There was significant difference between the case and control groups among the risk factors in calcium deficiency, lactose intolerance, history of corticosteroid drugs, methotrexate, anticonvulsants, disease of rheumatoid arthritis, hyperthyroidism, thalassemia minor and lower than 58kg weight.
Conclusion The factors such as diet and the lack of consumption of dairy products, pharmaceutical parameters including corticosteroids and Methotrexate and glandular or rheumatologic diseases are among the important and effective factors in reduction of bone density in postmenopausal women.
Methods In a descriptive cross-sectional study, 644 premenopausal women of military families who were referred to bone densitometry center of a hospital in Tehran participated in the research. Then, based on bone densitometry results the participants were divided into two groups: bone density loss 9 case groups) and normal bone density (control group). The information associated with risk factors of bone density loss were collected by osteoporosis Canadian standard questionnaire and was analyzed with chi square test and T-test.
Results Amount of spinal osteoporosis was 8.9% and the rate of osteopenia in these areas was 53.4%. There was significant difference between the case and control groups among the risk factors in calcium deficiency, lactose intolerance, history of corticosteroid drugs, methotrexate, anticonvulsants, disease of rheumatoid arthritis, hyperthyroidism, thalassemia minor and lower than 58kg weight.
Conclusion The factors such as diet and the lack of consumption of dairy products, pharmaceutical parameters including corticosteroids and Methotrexate and glandular or rheumatologic diseases are among the important and effective factors in reduction of bone density in postmenopausal women.
CITATION LINKS